RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 TAVR Suitable Procedure for High-Risk AS Patients: 5-Year Results from the PARTNER Trial
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 30
SP 9
OP 10
DO 10.1177/155989771430005
UL http://mdc.sagepub.com/content/14/30/9.abstract
AB One-, 2-, and 3-year data from the Placement of Aortic Transcatheter Valves study [PARTNER; NCT00530894] showed significant reductions in all-cause mortality, cardiac mortality, and rehospitalization [Kapadia SR et al. Circulation. 2014; Makkar RR et al. N Engl J Med. 2012; Leon MB et al. N Engl J Med. 2010]. This article reports the 5-year outcomes for the PARTNER trial.